Harmonic Discovery
We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing
Y Combinator
yc-company-directory #1944We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principle of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways. We are building a computational-experimental platform to design therapeutics that can target several disease-causing
sourceHarmonic Discovery is classified as Healthcare from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Harmonic Discovery
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Parallel Bio
match 85Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of nov
shared extracted concept terms: computational, drug; shared product terms: drug, discovery, complexity, disease; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
Origami Therapeutics, Inc.
match 82Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified sm
shared extracted concept terms: drug, discovery; shared product terms: drug, discovery, develop, therapeutic; shared product theme: health and clinical care; shared affiliation: Y Combinator
SynsoryBio
match 81SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
shared product terms: drug, generation, therapeutic, disease; shared product theme: health and clinical care; same category: Healthcare; shared affiliation: Y Combinator
NeuroX1
match 67Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.
shared extracted concept terms: computational, drug, discovery; shared product terms: drug, discovery, therapeutic, computational; shared product theme: health and clinical care
Forcyte Biotechnologies
match 52In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contr
shared product terms: many, disease, caus, drug; same category: Healthcare; shared affiliation: Y Combinator
Sequence Bio
match 4890% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.
shared extracted concept terms: drug, discovery; shared product terms: drug, discovery, target; same category: Healthcare; shared affiliation: Y Combinator